Atrisone dapsone topical gel: Phase I/II

In an open-label study of 48 patients, ATRX said that 1 and 5 percent Atrisone, applied once or twice daily, reduced inflammatory and non-inflammatory lesions by 50 percent during the 28-day study. Th...